Cel-Sci Corp
CVM·Stocks·Biotechnology·United States·NYSE·USD
Price
$1.70
Today
+1.8%
YTD
-66.9%
About
As a biotechnological company, CEL SCI Corporation specialises in immunotherapies to treat cancer, autoimmune, and infectious diseases. Established in 1983, the company is headquartered in Vienna, Virginia, and operates locally in the US. It trades on the NYSE using the CVM ticker. In December 2020, CEL SCI announced raising $14.65m with its offering that closed in the same month. Broaden your investment scope and buy CVM stock.
Price chart
Closing price history for CVM (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-0.40
P/S (TTM)0.00
P/B (TTM)1.70
Market cap$24.12M
Cap tierMicro-cap
Industry avg P/E-6.15
Profitability
Gross marginUnknown
EBIT margin0.00%
Net marginUnknown
ROE-305.27%
ROA-114.90%
Earnings & Revenue
Revenue (TTM)$0.00
Revenue growth (1Y)Unknown
EPS (TTM)-$3.48
Free cash flow$-16.66M
Total debt$8.51M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.02
EmployeesUnknown
Next earnings12 Feb '26
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.